European Archives - Page 291 of 1634 - European Medical Journal

ALA-DAG Oil

ALA-DAG Oil Improves Skin Hydration and Allergy Symptoms

ALA-DAG oil improved skin hydration and reduced allergic symptoms in adults with mild skin discomfort.

COVID-19: Not Gone, Just Gaining Ground Again

This comprehensive webinar brings together infectious disease specialists Andrew Ustianowski and Jacob Malin to discuss the current state…

Squamous Anal Cancer and CRC: From Diagnosis to Emerging Therapies

This Industry Satellite Symposium from ESMO 2025 brings together four leading experts, Sheela Rao, Christelle de la Fouchardière , Gunnar…

Advances in AD Outcomes

This promotional content is funded by Leo Pharma and is intended for healthcare professionals only. The medicinal product mentioned in…

Person looking into distance with telescope at arrow pointing upwards

UK clinical trial applications on the rise, finds MHRA

The 9% growth in 2025 could signal that the country is on track to become a more attractive destination for pharamceutical R&D.

Transforming Endometriosis Care: Interview with Andrew Horne

Transforming Endometriosis Care: Interview with Andrew Horne: Professor of Gynaecology and Reproductive SciencesThe University Edinburgh…

Reproductive Tract Microbiota Linked to Miscarriage Risk - EMJ

Changes in Reproductive Tract Microbiota Linked to Miscarriage Risk

A new systematic review found associations between alterations in the reproductive tract microbiota and miscarriage risk, with potential implications for reproductive health.

Phenotype-Specific Drivers of Quality of Life in IBD

Real-world data show distinct determinants of health-related quality of life in Crohn’s disease and ulcerative colitis, highlighting phenotype-specific roles of inflammation, imaging findings, treatment burden, and modifiable risk factors.

Kenneth Anderson, Director of the LeBow Institute and Jerome Lipper Myeloma Center at Dana-Farber.

Hema Now: Personalised Medicine and Immunotherapy in Multiple Myeloma

Kenneth Anderson, leading haematology expert at Dana-Farber, shares insights on multiple myeloma, drug resistance, key ASH updates, and turning…

Valve Implant Shows Durable Outcomes Beyond Five Years - EMJ

Valve Implant Shows Durable Outcomes Beyond Five Years

Across medium- and long-term follow-up, no patients developed valve stenosis or severe pulmonary regurgitation.